|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號：R100307 |
| 產(chǎn)品名稱：Raltegravir-13C,d3 |
| 產(chǎn)品CAS： |
| 規(guī)格含量：2.5mg |
| 產(chǎn)品價格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細介紹 |
| 標準品編號: |
R100307 |
| 名稱: |
Raltegravir-13C,d3 |
| 別名: |
N-[(4-Fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-4-pyrimidinecarboxamide-13C,d3; 5-Hydroxy-2-[1-[[(5-Methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]-1-methylethyl]-N-(4-fluorobenzyl)-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxamide-13C,d3; N-(4-Fluorobenzyl)-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-1,6-dihydropyrimidine-4-carboxamide-13C,d3 |
| 參考CAS號: |
Unlabeled: 518048-05-0 |
| 分子式: |
C??¹³CH??D?FN?O? |
| 分子量: |
448.43 |
| 類別: |
Standards; Isotopic Labeled Analogues; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應用: |
Raltegravir-13C,d3, is the labeled analogue of Raltegravir (MK-0518) (R100305), which is a potent integrase (IN) inhibitor for WT and S217Q PFV IN. |
| 參考文獻 |
|
|
|
|
?您的位置：
